| abstract |
A transdermal patch of rasagiline or pharmaceutically acceptable salts thereof for treating or preventing nervous system diseases. Particularly, a stable and release-controlled transdermal patch of rasagiline is provided, wherein the patch contains rasagiline or pharmaceutically acceptable salts thereof and at least one hydrophilic polymer matrix, moreover, the pH value of the patch is less than 7.0. The patch has predominant stability and can well control the transdermal release characteristics of rasageline. |